Full Text (PDF)
Review Article

Technology Playing Crucial Role in Early Diagnosis of Tuberculosis

Sachin C Narwadiya

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. 


Journal of Biochemistry and Biophysics 9(2):p 127-130, July-December 2024. | DOI: https://doi.org/10.21088/rfpjbb.2582-3558.9224.4

How Cite This Article:

Sachin C. Narwadiya, Technology Playing Crucial Role in Early Diagnosis of Tuberculosis. RFP Jour. of Bio. and Biophy. 2024;9(2): 127–130.

Timeline

Received : October 11, 2024         Accepted : November 25, 2024          Published : December 30, 2024

Abstract

Tuberculosis is a deadly disease that has hovered humanity for numerous decades. It’s caused by Mycobacterium tuberculosis. Tuberculosis(TB) exploration and invention are critical to achieving global TB targets that will help reduce TB prevalence and TB- related deaths. The WHO End Tuberculosis Strategy, espoused in 2014, envisages a 17 periodic decline in global TB prevalence between 2025 and 2035, compared to a reference line of 2 annually in 2015 and 20 in 2016. It’s conceded that achieving the unknown decline from 2025, it’ll bear significant technological advances, similar as the development of new TB vaccines that can be used both ahead and after infection by 2025.” Progress in exploration and invention” is the third pillar of the final TB law.


References

  • 1.   World Health Organization’s Consolidated guidelines on T.B. Diagnosis (2021) Rapid diagnostics for tuberculosis detection.
  • 2.   Global tuberculosis report 2020. WHO/HTM/ TB/2020.22, Geneva: World Health Organization; 2020
  • 3.   (https://www.who.int/publications/i/ item/9789240013131).
  • 4.   Implementing the End TB strategy: the essentials. Geneva: World Health Organization; 2015 (https:// www.who.int/tb/publications/2015/end_tb_ essential.pdf, accessed 26 May 2020).
  • 5.   American Red Cross. What is the nucleic acid test (NAT)?(https://www.sharecare.com/health/ blood-basics/what-is-the-nucleic-acid-test-n-a-t)
  • 6.   Line probe assays for drug-resistant tuberculosis detection: interpretation and reporting guide for laboratory staff and clinicians. Geneva: Global Laboratory Initiative; 2018 (http://www.stoptb. org/wg/gli/assets/documents/LPA_test_web_ ready.pdf, accessed 26 May 2020).
  • 7.   Report for WHO: non-inferiority evaluation of Nipro NTM+MDRTB and Hain GenoType MTBDRplus
  • 8.   V2 line probe assays. Geneva: Foundation for Innovative New Diagnostics; 2015 (http://www. finddx.org/wp-content/uploads/2016/04/LPA report_noninferiority-study_oct2015.pdf, accessed 26 May2020).
  • 9.   Feasey NA, Banada PP, Howson W, Sloan DJ, Mdolo A, Boehme C et al. Evaluation of Xpert MTB/RIF for detection of tuberculosis from blood samples of HIV-infected adults confirms Mycobacterium tuberculosis bacteremia as an indicator of poor prognosis. J Clin Microbiol. 2013;51(7):2311–6(https://pubmed.ncbi.nlm.nih. gov/23678061/, accessed 26 May 2020).

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding

Author Contributions

All authors contributed significantly to the work and approve its publication

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work


About this article


Cite this article

Sachin C. Narwadiya, Technology Playing Crucial Role in Early Diagnosis of Tuberculosis. RFP Jour. of Bio. and Biophy. 2024;9(2): 127–130.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. 


Received Accepted Published
October 11, 2024 November 25, 2024 December 30, 2024

DOI: https://doi.org/10.21088/rfpjbb.2582-3558.9224.4

Keywords

DiagnosisTuberculosisXpert MTB/ RIFTechnology

Article Level Metrics

Last Updated

Wednesday 14 October 2026, 07:24:37 (IST)


1486

Accesses

25
270
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received October 11, 2024
Accepted November 25, 2024
Published December 30, 2024

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. 


Access this article



Share